Intratumoral microorganisms and artificial antitumor bacteria
Authors:
- Wenna LiWLWenna Li
- Xiaotu MaXMXiaotu Ma
- Xiao ZhaoXZXiao Zhao
Open Access
- 1 September 2025
- journal article
- research article
- Published by KEAI Publishing in Fundamental Research
- Vol. 5 (5) , 2045-2048
Abstract
Intratumoral microorganisms have been detected in multiple cancer types, which can significantly affect the tumor progression and antitumor treatment efficacy. Considering the important role of intratumoral microorganisms in cancer development, novel therapeutic and diagnostic approaches based on living bacteria have received increasing attention in oncology. In addition to wild types, bacteria can also be programmed through synthetic biology techniques to enhance the spatial and temporal controllability. Therefore, once perfected, intratumoral microorganisms can be combined with immunotherapy or other powerful antitumor agents and possibly unlock the next generation of precision cancer diagnosis and therapy. Moreover, the current challenges and perspectives have also been discussed.Keywords
Funding Information
- National Key Research and Development Program of China Stem Cell and Translational Research (2021YFA0909900)
- National Natural Science Foundation of China (32171384, 32222045)
- Chinese Academy of Sciences (YSBR-010)
- Natural Science Foundation of Beijing Municipality (Z200020)
- Beijing Nova Program (Z201100006820031)
- National Key Research and Development Program of China
This publication has 14 references indexed in Scilit:
- Metabolic modulation of tumours with engineered bacteria for immunotherapyNature, 2021
- The human tumor microbiome is composed of tumor type–specific intracellular bacteriaScience, 2020
- RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approachNature, 2020
- Engineered probiotics for local tumor delivery of checkpoint blockade nanobodiesScience Translational Medicine, 2020
- Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer OutcomesCell, 2019
- Commensal Microbiota Promote Lung Cancer Development via γδ T CellsCell, 2019
- Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineScience, 2017
- S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fateNature, 2016
- Synchronized cycles of bacterial lysis for in vivo deliveryNature, 2016
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacyScience, 2015